Key statistics
As of last trade, Bergenbio ASA (7BG0:FRA) traded at 0.792, 14.45% above the 52 week low of 0.692 set on Sep 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.792 |
---|---|
High | 0.792 |
Low | 0.792 |
Bid | 0.828 |
Offer | 0.934 |
Previous close | 0.921 |
Average volume | 0.00 |
---|---|
Shares outstanding | 39.09m |
Free float | 22.95m |
P/E (TTM) | -- |
Market cap | 430.82m NOK |
EPS (TTM) | -5.37 NOK |
Data delayed at least 15 minutes, as of Oct 11 2024 08:17 BST.
More ▼
Press releases
- BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients
- BerGenBio Second Quarter Results 2024: Solid clinical and financial progress
- BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer
- BerGenBio Announces Selection of 2nd Dose in Phase 2a First Line STK11m Non-Small Lung Cancer Trial